Class / Patent application number | Description | Number of patent applications / Date published |
424778000 | Containing or obtained from a flower or blossom (aka flos) | 26 |
20080199550 | Novel Anticancer Agent, Methods for Obtaining the Same and Pharmaceutical Compositions Thereof - Disclosed herein a herbal anticancer agent comprising the extract of plant Sphaeranthus indicus or group of compounds obtained from the plant Sphaeranthus indicus. The present invention also discloses a pharmaceutical composition comprising the said agent, methods for preparing the composition and methods of treating all kinds of cancer in mammals including human beings. The methods of making the plant extract, methods for obtaining the active constituents are also dealt with. | 08-21-2008 |
20080220108 | Use of Hop Acids in Fruit Juices, Fruit Juice Concentrates and Other Beverages to Inhibit Alicyclobacillus Bacteria - An antimicrobial agent including hop acids is disclosed that inhibits the growth of acid-resistant and heat-resistant bacteria such as | 09-11-2008 |
20080248145 | Composition for a Feeling of Calmness - A method for promoting restful, quality sleep in an individual comprising the administration of a composition comprising Hops extract, | 10-09-2008 |
20090035403 | NOVEL ANTICANCER AGENT, METHODS FOR OBTAINING THE SAME AND PHARMACEUTICAL COMPOSITIONS THEREOF - Disclosed herein a herbal anticancer agent comprising the extract of plant | 02-05-2009 |
20090263522 | Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2 - A novel formulation is provided that serves to inhibit the inflammatory response in animals. The formulation comprises, as a first component an effective amount of a curcuminoid species and an effective amount of a second component selected from the group consisting of an alpha-acid species or a beta-acid species or derivatives thereof. The composition provides synergistic anti-inflammatory effects in response to physical or chemical injury or abnormal immune stimulation due to a biological agent or unknown etiology. | 10-22-2009 |
20090269427 | HERBAL COMPOSITION FOR INFLAMMATORY DISORDERS - This invention relates to a novel herbal composition comprising an extract of flowering and fruiting heads of the plant, | 10-29-2009 |
20090297646 | FEEDS CONTAINING HOP ACIDS AND USES THEREOF AS SUPPLEMENTS IN ANIMAL FEEDS - Disclosed are methods for administering hop acids to alter the microbial population of the gastrointestinal tract of animals and to inhibit the growth of pathogenic organisms in the gastrointestinal tracts of animals. Also disclosed are methods of increasing weight gain, feed efficiency, milk production in mammals, and egg and meat production in poultry by administering hop acids. Also disclosed are animal feeds containing hops and hop acids. | 12-03-2009 |
20100021575 | HYPOLIPIDEMIC COMPOSITION AND ITS USE - The present invention provides a hypolipidemic composition comprising peony extract and | 01-28-2010 |
20100092586 | Natural water soluble extracts for the inhibition of alpha-1-adrenergic receptors - The present invention discloses therapeutic natural products, in particular plant extracts effective in treating and preventing urinary tract disorders, and method for obtaining said extracts. In particular, the present invention discloses a water-soluble alcoholic extract of | 04-15-2010 |
20100159045 | COSMETIC USE OF ACTIVE AGENTS FOR STIMULATING THE EXPRESSION OF FN3K AND/OR FN3K RP TO IMPROVE THE SKIN'S BARRIER FUNCTION - A cosmetic process for caring for human skin, intended for preventing or combating the cutaneous signs resulting from non-pathological impairment of the barrier function, includes the topical application to the skin of a composition containing at least one active agent for stimulating the expression of FN3K and/or FN3K RP. The use of this active agent for preventing or combating the cutaneous signs resulting from non-pathological impairment of the barrier function is also disclosed. | 06-24-2010 |
20100196523 | Flower remedy beverage and method of making - A beverage and method of preparing a beverage comprising various combinations of flower essences designed for human consumption to treat emotional, mental and physical illnesses while providing hydration. In one illustrative embodiment of the method herein, a beverage is first formed by mixing a flower essence tincture with a diluent. A preservative flavoring and sweetener may also be added to the mixture. The beverage is then added to an empty container to form a filled container and then sealed to form a beverage product. The filled container may be sealed by, without limitation, applying a vacuum to the beverage therein, and/or capping an opening of the filled container. The capping may include applying a cap to the container, such as plastic or metallic cap. The container may be a plastic, glass or metallic bottle. | 08-05-2010 |
20100239697 | ABELMOSCHUS MANIHOT MEDICUS FLOWER PERFUMED PRODUCT - The Abelmoschus manihot Medicus flower perfumed product, which is made by immersing the Abelmoschus manihot Medicus flower containing volatile substance in Abelmoschus manihot Medicus oil, vegetable oil with more than 60% unsaturated fatty acid or cosmetic base oil grade mineral oil. The product using the edible oil and fat as the carrier can be used as food materials and that using mineral oil as the carrier can be used as the raw materials of medicine, skin care and hair care products. | 09-23-2010 |
20100303940 | SYNERGISTIC PEST-CONTROL COMPOSITIONS - Pest control compositions, blends, and formulations are disclosed. The blends contain, in a synergistic combinations, at least two ingredients such as Lilac Flower Oil, D-Limonene, Thyme Oil, Lime Oil, Black Seed Oil, Wintergreen Oil, Linalool, Tetrahydrolinalool, Vanillin, Isopropyl myristate, Piperonal (aldehyde), Geraniol, Geraniol 60, Triethyl Citrate, and Methyl Salicylate. | 12-02-2010 |
20100310690 | Pharmaceutical product and analysis model for hormone replacement therapy for women and prevention of some cancers and uterine myomas - The present disclosure describes a study of estrogenic activity present in various plant species, selectively inducing some but not all estrogenic responses in the uterus. Prepubertal female rats were treated sequentially with various extracts or decoctions of different plant species or its vehicle, followed 1 h later by treatment with estradiol-17β (E) or its solvent. Uteri were excised under anesthesia and histologically processed for eosinophil quantification and morphometric evaluation of various uterine responses to estrogen, at 6 or 24 h after hormone or vehicle treatment. Besides extracts or decoctions, pure phytoestrogens were also used. Additionally, human mammary cancer cells MCF-7 or MDAMB-231 were cultured in presence of the extract (or decoction), E, both or solvent and cell proliferation was evaluated. Various extracts or decoction displayed selective estrogenic and/or antiestrogenic action for some but not all parameters of estrogen stimulation in the uterus and inhibited growth of human mammary cells in culture or antagonized the estrogen-induced increase in their growth. Present results reveal, for the first time, a dissociation of responses to estrogen by phytoestrogens, suggesting its possible therapeutic application as estrogenic compounds not inducing cell proliferation and reveal the anticancerous effect of some of the extracts with possible therapeutic relevance. The dissociation of responses to estrogen additionally suggest therapeutic applications in estrogen-related diseases (for instance, premenstrual syndrome, endometriosis, etc.); the inhibition of eosinophil degranulation suggest an application in diseases related to eosinophils (hypereosinophilic syndrome, allergic and hypersensitivity diseases). | 12-09-2010 |
20100323046 | NOVEL USES OF HIBISCUS, IN PARTICULAR PHARMACEUTICAL USES - The invention relates to the use of | 12-23-2010 |
20100330215 | Methods of Administering Anti-Inflammatory Cyclooxygenase-2 Selective Inhibitors - Disclosed are novel anti-inflammatory pharmaceutical compositions and related methods that exhibit potent and selective inhibition of the cycloooxygenase-2 (COX-2) enzyme. The formulation can comprise a hops extract that exhibits COX-2 selectivity as defined by dividing the IC50 COX-2/IC50COX-1 concentrations that are determined by testing with the William Harvey Whole Blood Assay (WHMA), and can fall within the range of 0.011 to 0.2. Such compositions may also optionally contain high levels of alpha acids and low levels of beta acids, some flavonoid compounds, and virtually no essential oils. Such compositions are useful for treating conditions that manifest as inflammatory pain, or are impacted by the COX-2 enzyme. The recited compositions are particularly beneficial for treating osteoarthritis and rheumatoid arthritis, and can be used for chronic pain with reduced gastric side-effects. | 12-30-2010 |
20110311663 | FEEDS CONTAINING HOP ACIDS AND USES THEREOF AS SUPPLEMENTS IN ANIMAL FEEDS - Disclosed are methods for administering hop acids to alter the microbial population of the gastrointestinal tract of animals and to inhibit the growth of pathogenic organisms in the gastrointestinal tracts of animals. Also disclosed are methods of increasing weight gain, feed efficiency, milk production in mammals, and egg and meat production in poultry by administering hop acids. Also disclosed are animal feeds containing hops and hop acids. | 12-22-2011 |
20120189725 | Topical Skin Care Formulations Comprising Botanical Extracts - Disclosed is a topical skin composition comprising an aqueous extract from a part of | 07-26-2012 |
20120276231 | METHOD FOR PRODUCING ABELMOSCHUS MANIHOT MEDICUS FLOWER PERFUMED PRODUCT - A producing method of | 11-01-2012 |
20130266677 | TOPICAL SKIN CARE FORMULATIONS COMPRISING BOTANICAL EXTRACTS - Disclosed is a topical skin composition comprising an aqueous extract from a part of | 10-10-2013 |
20150044316 | METHOD FOR PREPARING A PURIFIED EXTRACT OF LONICERA JAPONICA THUNBERG AND THE COMPOSITION COMPRISING THE SAME FOR PREVENTING AND TREATING SEPSIS AND SEPTIC SHOCK - The present invention relates to a method for preparing a purified extract of | 02-12-2015 |
20150050375 | TOTAL FLAVONE EXTRACT OF FLOWER OF ABELMOSCHUS MANIHOT L. MEDIC AND PREPARATION METHOD THEREOF - Disclosed are a total flavone extract of | 02-19-2015 |
20150366923 | ALLAMANDA CATHARTICA EXTRACTS AND METHODS OF USE - Methods of using extracts of | 12-24-2015 |
20160136220 | Molecular and Herbal Combinations for Treating Psoriasis - A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including emodin and digoxin, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang, Jin Yin Hua, Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi. | 05-19-2016 |
20160184380 | Molecular Combinations for Cancer or Other Disease Treatment - A method and medicine for treating leukemia or other cancer or disease condition including administering periodic doses of a combination of one or more of emodin, rhein or rhapontin with one or more of aucubin, digoxin or beta-sitosterol, and/or one or more of carvacrol, vanillic acid or sitosterol. | 06-30-2016 |
20160193263 | REACTION PLATFORM AND METHOD FOR MAKING POLLEN BASED MATERIALS IN COMBINATION WITH BEESWAX AND USES THEREOF | 07-07-2016 |